GABAB receptor-positive modulation decreases selective molecular and behavioral effects of cocaine

Neuropsychopharmacology

Volumn 32, Issue 2, 2007, Pages 388-398

  Lhuillier, Loic ^a   Mombereau, Cedric ^a   Cryan, John F ^a,b   Kaupmann, Klemens ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

FosB; Abuse; Addiction; CREB; Dopamine; GS39783

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; GS 39783; N,N' DICYCLOPENTYL 2 METHYLSULFANYL 5 NITROPYRIMIDINE 4,6 DIAMINE; PHOSPHOPROTEIN DARPP 32; PROTEIN FOS; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; IMMUNOBLOTTING; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STRIATE CORTEX; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; BACLOFEN; BEHAVIOR, ADDICTIVE; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOPENTANES; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; HYPERKINESIS; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-FOS; PYRIMIDINES; RECEPTORS, GABA-B; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 33846253620     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301102     Document Type: Article

References (60)

1. Adams JU, Careri JM, Efferen TR, Rotrosen J (2001). Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats. Behav Pharmacol 12: 603-611.
2. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L et al(2002). Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37: 504-508.
3. Anderson SM, Pierce RC (2005). Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther 106: 389-403.
4. Bettler B, Kaupmann K, Mosbacher J, Gassmann M (2004). Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 84: 835-867.
5. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL et al(2001). Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410: 376-380.
6. Brebner K, Childress AR, Roberts DC (2002). A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 37: 478-484.
7. Brebner K, Phelan R, Roberts DC (2000). Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 66: 857-862.
8. Chen Y, Phillips K, Minton G, Sher E (2005). GABA(B) receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area. Br J Pharmacol 144: 926-932.
9. Colby CR, Whisler K, Steffen C, Nestler EJ, Self DW (2003). Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci 23: 2488-2493.
10. Cousins MS, Roberts DC, de Wit H (2002). GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65: 209-220.
11. Cryan JF, Gasparini F, van Heeke G, Markou A (2003). Nonnicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. Drug Discov Today 8: 1025-1034.
12. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K et al(2004). Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N′-dicyclopentyl-2- methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 310: 952-963.
13. Curran EJ, Akil H, Watson SJ (1996). Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res 21: 1425-1435.
14. Erhardt S, Mathe JM, Chergui K, Engberg G, Svensson TH (2002). GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn Schmiedebergs Arch Pharmacol 365: 173-180.
15. Fadda P, Scherma M, Fresu A, Collu M, Fratta W (2003). Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50: 1-6.
16. Giorgetti M, Hotsenpiller G, Froestl W, Wolf ME (2002). In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment. Neuroscience 109: 585-595.
17. Gong W, Neill DB, Justice Jr JB (1998). GABAergic modulation of ventral pallidal dopamine release studied by in vivo microdialysis in the freely moving rat. Synapse 29: 406-412.
18. Graybiel AM, Moratalla R, Robertson HA (1990). Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87: 6912-6916.
19. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y et al(1994). Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13: 1235-1244.
20. Hotsenpiller G, Wolf ME (2003). Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in rat nucleus accumbens. Neuroscience 118: 123-134.
21. Hu XT, Ford K, White FJ (2005). Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons. Neuropsychopharmacology 30: 916-926.
22. Jacobson LH, Cryan JF (2005). Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains. Psychopharmacology (Berlin) 179: 688-699.
23. Johnson SW, North RA (1992). Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450: 455-468.
24. Kalivas PW (1993). Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18: 75-113.
25. Kalivas PW, Churchill L, Klitenick MA (1993). GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57: 1047-1060.
26. Kalivas PW, Stewart J (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16: 223-244.
27. Kalivas PW, Volkow ND (2005). The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413.
28. Kano T, Suzuki Y, Shibuya M, Kiuchi K, Hagiwara M (1995). Cocaine-induced CREB phosphorylation and c-Fos expression are suppressed in Parkinsonism model mice. Neuroreport 6: 2197-2200.
29. Kelz MB, Chen J, Carlezon Jr WA, Whisler K, Gilden L, Beckmann AM et al(1999). Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401: 272-276.
30. Kuczenski R (1983). Biochemical actions of amphetamine and other stimulants. In: Creese I (ed). Biochemical Actions of Amphetamine and Other Stimulants Neurochemical, Behavioral and Clinical Perspectives. Raven Press: New York. pp 31-61.
31. Lacey MG (1993). Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area. Prog Brain Res 99: 251-276.
32. Leite-Morris KA, Fukudome EY, Kaplan GB (2002). Opiateinduced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neurosci Lett 317: 119-122.
33. Lin XH, Hashimoto T, Kitamura N, Murakami N, Shirakawa O, Maeda K (2002). Decreased calcineurin and increased phosphothreonine-DARPP-32 in the striatum of rats behaviorally sensitized to methamphetamine. Synapse 44: 181-187.
34. Liu QS, Pu L, Poo MM (2005). Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437: 1027-1031.
35. McClung CA, Nestler EJ (2003). Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 6: 1208-1215.
36. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ (2004). DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 132: 146-154.
37. Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF (2004). Genetic and pharmacological evidence of a role for GABA (B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 29: 1050-1062.
38. Muller DL, Unterwald EM (2005). D1 dopamine receptors modulate {Delta}FosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 314: 148-154.
39. Nestler EJ, Aghajanian GK (1997). Molecular and cellular basis of addiction. Science 278: 58-63.
40. Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P (2000). Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci USA 97: 12840-12845.
41. Nye HE, Hope BT, Kelz MB, Iadarola M, Nestler EJ (1995). Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther 275: 1671-1680.
42. Olpe HR, Koella WP, Wolf P, Haas HL (1977). The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area. Brain Res 134: 577-580.
43. O'Neill MF, Shaw G (1999). Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berlin) 145: 237-250.
44. Paxinos G, Franklin KBJ (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: San Diego.
45. Perrotti LI, Bolanos CA, Choi KH, Russo SJ, Edwards S, Ulery PG et al(2005). DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 21: 2817-2824.
46. Pierce RC, Kalivas PW (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25: 192-216.
47. Shaywitz AJ, Greenberg ME (1999). CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68: 821-861.
48. Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC et al(2003). Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64: 1440-1448.
49. Slattery DA, Markou A, Froestl W, Cryan JF (2005). The GABA(B) receptor-positive modulator GS39783 and the GABA(B) receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30: 2065-2072.
50. Smith MA, Yancey DL, Morgan D, Liu Y, Froestl W, Roberts DC (2004). Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology (Berlin) 173: 105-111.
51. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ (1991). A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548: 100-110.
52. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W et al(2003). N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro- pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J Pharmacol Exp Ther 307: 322-330.
53. Volkow ND, Li TK (2004). Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 5: 963-970.
54. Westerink BH, Kwint HF, deVries JB (1996). The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 16: 2605-2611.
55. Wirtshafter D, Sheppard AC (2001). Localization of GABA(B) receptors in midbrain monoamine containing neurons in the rat. Brain Res Bull 56: 1-5.
56. Wu YN, Shen KZ, Johnson SW (1999). Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons. Br J Pharmacol 127: 1422-1430.
57. Young ST, Porrino LJ, Iadarola MJ (1991). Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci USA 88: 1291-1295.
58. Yun IA, Wakabayashi KT, Fields HL, Nicola SM (2004). The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues. J Neurosci 24: 2923-2933.
59. Zhang D, Zhang L, Lou DW, Nakabeppu Y, Zhang J, Xu M (2002). The dopamine D1 receptor is a critical mediator for cocaineinduced gene expression. J Neurochem 82: 1453-1464.
60. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y et al(2004). Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 24: 3344-3354.